Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,614,270
+$174,922 QoQ
Shares Held
6,415
-3.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#2,129
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GWN SECURITIES INC. holds $16,786,719 across 9 Drug Manufacturers - General names. ABBV ranks #3 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,279 | $5,658,197 | |
| 2 | LLY |
ELI LILLY & Co
|
4,579 | $5,492,190 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
6,415 | $1,614,270 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
10,108 | $1,277,044 | |
| 5 | AMGN |
Amgen Inc
|
2,602 | $942,236 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,853 | $913,449 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,769 | $355,816 | |
| 8 | PFE |
Pfizer Inc
|
13,452 | $323,924 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,614,270 | 6,415 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,439,348 | 6,618 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,449,312 | 6,343 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,198,914 | 5,178 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $1,006,988 | 5,425 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $13,932,451 | 66,497 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,503,793 | 14,090 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||